Chitosan Oligosaccharide (COS)
Chitosan oligosaccharide (COS) is a low molecular weight derivative of chitosan that inhibits pancreatic lipase enzyme to reduce dietary fat absorption. Its oligomeric structure allows for enhanced bioavailability and prebiotic activity compared to regular chitosan.

Origin & History
Chitosan oligosaccharide is a low-molecular-weight derivative of chitosan, produced through enzymatic hydrolysis. It is sourced from crustacean shells.
Historical & Cultural Context
While a relatively new derivative, chitosan oligosaccharide builds on the traditional use of chitosan in various cultures for health benefits.
Health Benefits
- Chitosan Oligosaccharide (COS) supports weight management by inhibiting the absorption of dietary fats. This can lead to a reduction in overall calorie intake and support a healthy weight. - It enhances gut health by acting as a prebiotic, promoting the growth of beneficial gut bacteria. This improves digestion and nutrient absorption. - COS boosts immune function by enhancing the activity of immune cells, such as macrophages. This strengthens the body's defense against infections. - It supports cardiovascular health by reducing LDL cholesterol levels and improving blood lipid profiles. This promotes heart health and reduces the risk of cardiovascular diseases. - COS has antioxidant properties that help neutralize free radicals, reducing oxidative stress and supporting cellular health. - It can improve skin health by enhancing skin barrier function and hydration. This helps maintain skin elasticity and reduces dryness. - COS promotes wound healing by accelerating tissue regeneration and reducing inflammation. This leads to faster recovery and less scarring.
How It Works
COS inhibits pancreatic lipase activity in the small intestine, preventing the breakdown and absorption of dietary triglycerides. It also acts as a prebiotic by selectively promoting the growth of beneficial bacteria like Lactobacillus and Bifidobacterium through its oligomeric carbohydrate structure. The low molecular weight (typically <10 kDa) enhances solubility and biological activity compared to high molecular weight chitosan.
Scientific Research
Preliminary studies suggest chitosan oligosaccharide may support immune function and gut health. More research, including RCTs, is needed to confirm these effects.
Clinical Summary
Human studies on COS for weight management show modest results, with 12-week trials demonstrating 2-4 kg additional weight loss when combined with calorie restriction. A randomized controlled trial of 96 participants found COS supplementation increased beneficial gut bacteria counts by 40-60% after 8 weeks. Most clinical evidence comes from small-scale studies (30-100 participants) lasting 8-16 weeks. Larger, longer-term studies are needed to confirm therapeutic efficacy and optimal dosing protocols.
Nutritional Profile
Chitosan Oligosaccharide (COS) is a low-molecular-weight oligomer (typically 2–10 glucosamine units, MW ~1–10 kDa) derived from the enzymatic or chemical hydrolysis of chitosan, which itself is obtained by deacetylation of chitin. It is not a significant source of macronutrients (negligible fat, negligible digestible carbohydrate energy, and no complete protein). Key bioactive characteristics include: **Primary bioactive compound:** β-1,4-linked D-glucosamine oligomers with a degree of deacetylation (DD) typically ≥85–95%, conferring a polycationic character at physiological pH. **Amino sugar content:** Predominantly composed of D-glucosamine (2-amino-2-deoxy-D-glucose) residues, with minor residual N-acetyl-D-glucosamine units (~5–15% depending on DD). Glucosamine content per gram of COS is approximately 700–850 mg. **Molecular weight range:** Typical commercial COS preparations range from ~0.5 kDa (disaccharides) to ~10 kDa (decamers); lower MW fractions (1–3 kDa) generally exhibit superior water solubility (>99% soluble) and higher bioavailability compared to parent chitosan. **Ash/minerals:** Trace minerals may be present depending on source — calcium (1–3 mg/g), sodium (<5 mg/g), and trace amounts of magnesium and potassium from crustacean shell origin. **Fiber classification:** COS is classified as a soluble dietary fiber analog; however, it is largely non-caloric (~0 kcal/g metabolizable energy) as human digestive enzymes do not efficiently cleave the β-1,4-glycosidic bonds. **Nitrogen content:** Approximately 7–8% nitrogen by weight, attributable to free amino groups on glucosamine residues. **Bioavailability notes:** Unlike high-molecular-weight chitosan (which has poor solubility and <5% oral absorption), COS demonstrates high aqueous solubility across a broad pH range (pH 2–9) and significantly enhanced intestinal absorption — estimated oral bioavailability of 20–30% for oligomers ≤5 kDa, with smaller fragments (di- to pentamers) showing the highest absorption via paracellular and transcellular intestinal transport. COS is absorbed intact in the small intestine and can be detected in systemic circulation. **No vitamins** are inherently present. **No significant lipid or protein content.** The polycationic nature (pKa of amino groups ~6.3–6.5) is central to its fat-binding capacity (estimated ~3–5 g dietary fat bound per gram COS in vitro at gastric pH), its mucoadhesive properties, and its electrostatic interaction with bacterial cell membranes underlying antimicrobial activity.
Preparation & Dosage
Dosage is not standardized; consult a healthcare provider for guidance. Consult a healthcare provider before use.
Synergy & Pairings
Probiotics, Prebiotics, Zinc
Safety & Interactions
COS is generally well-tolerated with mild gastrointestinal side effects including bloating, gas, and loose stools reported in some users. It may reduce absorption of fat-soluble vitamins (A, D, E, K) when taken with meals containing these nutrients. Individuals with shellfish allergies should exercise caution as COS is typically derived from crustacean shells. Safety during pregnancy and breastfeeding has not been established, so use should be avoided during these periods.